MX360905B - Polimixinas, composiciones, metodos de preparacion y metodos de uso. - Google Patents

Polimixinas, composiciones, metodos de preparacion y metodos de uso.

Info

Publication number
MX360905B
MX360905B MX2015008878A MX2015008878A MX360905B MX 360905 B MX360905 B MX 360905B MX 2015008878 A MX2015008878 A MX 2015008878A MX 2015008878 A MX2015008878 A MX 2015008878A MX 360905 B MX360905 B MX 360905B
Authority
MX
Mexico
Prior art keywords
methods
polymyxins
compositions
making
xch2n
Prior art date
Application number
MX2015008878A
Other languages
English (en)
Other versions
MX2015008878A (es
Inventor
Gunnes Sølvi
Bjørnstad Vidar
Koch Torben
Melander Claes
Mänsson Martin
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Publication of MX2015008878A publication Critical patent/MX2015008878A/es
Publication of MX360905B publication Critical patent/MX360905B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)

Abstract

La presente invención se refiere a una composición que comprende cuando menos una polimixina o una sal de ésta representada por la fórmula (I). (ver Fórmula) en donde: R1 es un grupo acilo C6-C10 alifático, ramificado o lineal, o (ver Fórmula) R5 es -CH(CH3)2, -CH2CH(CH3)2, -CH(CH3)CH2CH3, o -CH2C6H5; R6 es -CH(CH3)2, -CH2CH(CH3)2, o -CH(CH3)CH2CH3; cada uno de R2,R3,R4, R7 y R8 es ya sea -(CH2)XCH2NH2 o - (CH2)XCH2N(CH2SO3M)2; en donde x es 0 o 1;en donde M es un catión monovalente; y en donde cuando menos tres de R2,R3,R4,R7 y R8 son -(CH2)XCH2N(CH2SO3M)2.
MX2015008878A 2013-01-11 2014-01-09 Polimixinas, composiciones, metodos de preparacion y metodos de uso. MX360905B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US201361904793P 2013-11-15 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (2)

Publication Number Publication Date
MX2015008878A MX2015008878A (es) 2015-10-30
MX360905B true MX360905B (es) 2018-11-21

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008878A MX360905B (es) 2013-01-11 2014-01-09 Polimixinas, composiciones, metodos de preparacion y metodos de uso.

Country Status (20)

Country Link
US (1) US10640536B2 (es)
EP (1) EP2943503B1 (es)
JP (1) JP6316846B2 (es)
KR (1) KR20150107793A (es)
CN (1) CN104918951B (es)
AU (1) AU2014204873B2 (es)
BR (1) BR112015016548A2 (es)
CA (1) CA2895910C (es)
EA (1) EA027067B1 (es)
ES (1) ES2641017T3 (es)
HU (1) HUE034562T2 (es)
IL (1) IL239840A (es)
MX (1) MX360905B (es)
PT (1) PT2943503T (es)
RU (1) RU2015132569A (es)
SI (1) SI2943503T1 (es)
TW (1) TWI613219B (es)
UA (1) UA117673C2 (es)
WO (1) WO2014108469A1 (es)
ZA (1) ZA201504565B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX360905B (es) 2013-01-11 2018-11-21 Xellia Pharmaceuticals Aps Polimixinas, composiciones, metodos de preparacion y metodos de uso.
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
EP3166960B1 (en) 2014-07-09 2019-08-07 Xellia Pharmaceuticals ApS Low substituted polymyxins and compositions thereof
KR102433278B1 (ko) 2014-10-03 2022-08-16 셀리아 파마슈티칼즈 에이피에스 조성물
PT3200762T (pt) 2014-10-03 2019-05-28 Xellia Pharmaceuticals Aps Dispositivo de inalação
JP6896628B2 (ja) 2014-12-16 2021-06-30 シャンハイ ミクウルク ファーマシューティカル シーオー.エルティーディー 細菌感染症の治療のための抗微生物性ポリミキシン
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US11225505B2 (en) 2015-09-29 2022-01-18 Monash University Antimicrobial polymyxin derivative compounds
WO2018103758A1 (zh) * 2016-12-09 2018-06-14 上海医药工业研究院 高效价的多黏菌素e2甲磺酸钠
CN115298198A (zh) 2020-01-21 2022-11-04 上海盟科药业股份有限公司 用于肾相关癌症靶向治疗的新型化合物和组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (es) * 1968-02-12 1970-03-06
WO1989009626A1 (en) 1988-04-07 1989-10-19 Luther Ronald B Non-thrombogenic intravascular time release catheter
DE69705414T2 (de) 1996-11-15 2002-05-02 Pathogenesis Corp., Seattle Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US20030143162A1 (en) 2001-05-18 2003-07-31 Speirs Robert John Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
US8193354B2 (en) * 2005-10-28 2012-06-05 Arch Pharmalabs Limited Process for preparation of Gemcitabine hydrochloride
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
MX360905B (es) 2013-01-11 2018-11-21 Xellia Pharmaceuticals Aps Polimixinas, composiciones, metodos de preparacion y metodos de uso.
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
EP3166960B1 (en) 2014-07-09 2019-08-07 Xellia Pharmaceuticals ApS Low substituted polymyxins and compositions thereof
KR102433278B1 (ko) 2014-10-03 2022-08-16 셀리아 파마슈티칼즈 에이피에스 조성물

Also Published As

Publication number Publication date
MX2015008878A (es) 2015-10-30
EA027067B1 (ru) 2017-06-30
IL239840A (en) 2017-09-28
UA117673C2 (uk) 2018-09-10
JP6316846B2 (ja) 2018-04-25
EP2943503B1 (en) 2017-08-23
BR112015016548A2 (pt) 2017-07-11
US10640536B2 (en) 2020-05-05
CA2895910A1 (en) 2014-07-17
PT2943503T (pt) 2017-09-28
TWI613219B (zh) 2018-02-01
WO2014108469A1 (en) 2014-07-17
US20160002296A1 (en) 2016-01-07
CN104918951A (zh) 2015-09-16
JP2016505007A (ja) 2016-02-18
CN104918951B (zh) 2018-03-30
CA2895910C (en) 2021-12-21
HUE034562T2 (en) 2018-03-28
SI2943503T1 (sl) 2017-11-30
IL239840A0 (en) 2015-08-31
RU2015132569A (ru) 2017-02-14
AU2014204873A1 (en) 2015-07-09
TW201429995A (zh) 2014-08-01
EP2943503A1 (en) 2015-11-18
ES2641017T3 (es) 2017-11-07
ZA201504565B (en) 2016-11-30
EA201591280A1 (ru) 2015-12-30
KR20150107793A (ko) 2015-09-23
AU2014204873B2 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
MX2015008878A (es) Polimixinas, composiciones, metodos de preparacion y metodos de uso.
MX2015009591A (es) Amidas como moduladores de canales de sodio.
MX2015009602A (es) Piridona amidas como moduladores de canales de sodio.
NZ716840A (en) Combination formulation of two antiviral compounds
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
CU24377B1 (es) Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
BR112018003026A2 (pt) composições compreendendo um inibidor de pi3k e um inibidor de hdac
BR112014011938A2 (pt) combinação de formulação de dois compostos antivirais
MA38982A1 (fr) Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl
IN2015MN00405A (es)
CR20140091A (es) Nuevos derivados dihidroquinolina-2-ona
PH12017500513A1 (en) N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of nr2b
MX373622B (es) Mezclas de compuestos, su preparación y sus usos.
MX356342B (es) Agente de control de endoparásitos y método para usarlo.
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
DOP2014000178A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
SG10201803294PA (en) Tau imaging probe
MY179145A (en) Skin cleansing composition
NZ703217A (en) Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same
PH12018500695A1 (en) Oral care compositions and methods of using the compositions
MA58019B1 (fr) Thienyloxazolones et analogues
UY37443A (es) Derivados de fenilamina sustituidos en la posición 4 y uso de los mismos para proteger los cultivos combatiendo los microorganismos fitopatógenos no deseados
SG10201805880UA (en) Emulsion composition for skin
MX380583B (es) Insecticidas de 1-aril-3-alquilpirazol.

Legal Events

Date Code Title Description
FG Grant or registration